Critical Flicker Fusion Test
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
Démences (vasculaire et Alzheimer)
Alzheimer Disease as a Vascular Disorder
Insulin Signaling in Alzheimer’s Disease : Association with Brain Insulin Resistance
Older adults at greater risk for Alzheimer’s disease show stronger associations between sleep apnea severity in REM sleep and verbal memory
Incidence of Dementia and Alzheimer Disease in 2 Communities
Cerebral Cysticercosis Presenting as Progressive Dementia
Extracranial Vascular Arterial Stiffness Contributes to Cerebral Small Vessel Disease, Stroke, and Late-Onset Alzheimer’s Disease
Exercise Intervention for Alzheimer’s Disease: Unraveling Neurobiological Mechanisms and Assessing Effects
Impact of Mouthwash-Induced Oral Microbiome Disruption on Alzheimer’s Disease Risk
Multidomain therapy for Alzheimer’s disease
Sustained Cognitive Improvement in Alzheimer’s Disease Patients Following a Precision Medicine Protocol
Basic Mechanisms of Brain Injury and Cognitive Decline in Hypertension
Hypertension and Dementia
Capillary Dysfunction : Its Detection and Causative Role in Dementias and Stroke
Current updates on latest basic research of scientific relevance in hypertensive dementia
Impact of Sleep Disorders and Disturbed Sleep on Brain Health
Microbiota–gut–brain axis in neurodegenerative diseases
The role of gut microbiota in pathogenesis of Alzheimer Disease
Functional amyloid – from bacteria to humans
Brain-targeting autoantibodies in patients with dementia
Neuronal surface autoantibodies in dementia
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types
Brain atrophy patterns in anti-IgLON5 disease
Brainstem pathology in anti-IgLON5 disease
Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5
The role of brain MRI in autoimmune encephalitis.
Imaging biomarkers in antibody-mediated autoimmune encephalitis
Multi-omics integration in autoimmune encephalitis
Current and Future Biomarkers in the Diagnosis of Autoimmune Encephalitis
Antineuronal antibody titres in autoimmune encephalitis
Severe Abdominal Pain as a Prominent Clinical Manifestation of Anti-DPPX Autoimmune Encephalitis
Anti-dipeptidyl-peptidase-like protein 6 encephalitis with pure cerebellar ataxia
Anti-dipeptidyl-peptidase-like protein-6 (DPPX) autoimmune encephalitis associated with severe multifocal dystonia
Treatable Rapid Progressive Dementia: A First Case Report of Anti-dipeptidyl-peptidase-like Protein 6 Encephalitis
Pain in anti-DPPX encephalitis
Critical Flicker Fusion Test
Assessing the Relationship Between the Flicker Test and Cognitive Performance
Critical Flicker Fusion Predicts Executive Function in Younger and Older Adults
Critical Flicker Fusion Threshold in patients with Alzheimer’s disease and vascular dementia
Critical Flicker Fusion Threshold : A Potentially Useful Measure for the Early Detection of Alzheimer’s Disease
The speed of sight : Individual variation in critical flicker fusion thresholds
IODE – VITAMINES
Iodine Deficiency and the Brain : Effects and Mechanisms
Vitamin deficiencies and Alzheimer’s disease
Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults
Association of vitamin D with risk of dementia
Vitamin D and the risk of dementia and Alzheimer disease
Biometals in Alzheimer disease- emerging therapeutic and diagnostic potential of molybdenum and iodine
Thyroid dysfunction and Alzheimer’s disease, a vicious circle
The Association Between Thyroid Diseases and Alzheimer’s Disease in a National Health Screening Cohort in Korea
Thyroid Dysfunction and Risk of Parkinson’s Disease
THERAPEUTIQUE
Non Pharmaceutical Interventions for Alzheimers Disease The Role of Diet Exercise and Sleep in Slowing Disease Progression
Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation
Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation
DMSO Delays Alzheimer Disease Causing Aβ-induced Paralysis in C. elegans Through Modulation of Glutamate:Acetylcholine Neurotransmission
Exercise-regulated bone–brain axis: A novel perspective on age-related cognitive decline
Exercise Intervention Associated with Cognitive Improvement in Alzheimer’s Disease
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI
Reversal of cognitive decline : a novel therapeutic program
Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration
Psilocybin for the treatment of Alzheimer’s disease
Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration